NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to 1 Million at a 15 percent ...
| NLSPW Stock | USD 0.01 0.01 83.33% |
Slightly above 53% of NLS Pharmaceutics' sophisticated investors are presently thinking to get in. The analysis of the overall investor sentiment regarding NLS Pharmaceutics AG suggests that some traders are interested. NLS Pharmaceutics' investing sentiment can be driven by a variety of factors including economic data, NLS Pharmaceutics' earnings reports, geopolitical events, and overall market trends.
NLS |
PR NewswireZURICH, Dec. 4, 2024 ZURICH, Dec. 4, 2024 PRNewswire -- NLS Pharmaceutics Ltd. , a Swis
Read at gurufocus.com
 |
NLS Pharmaceutics Fundamental Analysis
We analyze NLS Pharmaceutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NLS Pharmaceutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NLS Pharmaceutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
NLS Pharmaceutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
NLS Pharmaceutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NLS Pharmaceutics stock to make a market-neutral strategy. Peer analysis of NLS Pharmaceutics could also be used in its relative valuation, which is a method of valuing NLS Pharmaceutics by comparing valuation metrics with similar companies.
Peers
NLS Pharmaceutics Related Equities
| GOVXW | GeoVax Labs | 9.09 | ||||
| RVPHW | Reviva Pharmaceuticals | 6.67 | ||||
| NLSP | NLS Pharmaceutics | 18.07 |
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.